Over the last two decades, the ability to diagnose and treat osteoporosis has dramatically improved. The advances in treatment of osteoporosis have unfortunately been underutilized in non-caucasian populations. Researchers have highlighted that the current guidelines for screening and treatment are primarily based on data obtained from studies of postmenopausal Caucasian women, as insufficient data is […]
Preventive Medicine and Screening The demographics of the patients included in the chart review are shown in Table 1. The mean age of the group was 69.6 years (range 53-94). Of the 252 women, only 11.5% had documentation of prior central bone densitometry (DEXA). Nearly 39% of the women were counseled about calcium and/or vitamin-D […]
Setting This study was completed in the Medicine Clinic at Barnes-Jewish Hospital at the Washington University Medical Center in St. Louis, MO. Approximately 160 internal medicine residents see patients in this urban clinic, which had over 31,000 patient visits in 2000. The clinic serves primarily middle-aged and elderly adults from minority ethnic groups. In 2000, […]
INTRODUCTION is a metabolic bone disorder that affects more than 25 million Americans. Osteoporosis is characterized by low bone mass, which makes bones fragile and susceptible to fractures.
To our knowledge, this is the first study to examine the prevalence of low bone density in African-American patients with RA (including patients with either early or established disease). Depending on the race/ethnicity of the reference population used, we found that approximately one-third to half of patients were osteopenic or worse, and 5-16% were osteoporotic […]
Patient Characteristics Characteristics of the 175 study participants are summarized in Table 2. Study participants had a mean age of 51 ± 13 years and were predominantly women (n=144, 82%). Patients had a mean RA disease duration of 14 ± 7 months and a substantial majority of participants (n=145, 83%) had received prior treatment with […]
Patients Participants were enrollees in the Consortium for the Longitudinal Evaluation of African Americans with Early Rheumatoid Arthritis (CLEAR). Eligible participants self-reported African-American ethnicity, had an established diagnosis of RA as defined by the American College of Rheumatology (ACR) classification criteria and had <2 years of disease duration (from time of symptom onset). All patients […]